← Back to Search

Monoclonal Antibodies

xolair for Asthma

N/A
Waitlist Available
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mild asthma, adults -
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anti-KLH Antibody. This is Measured by ELISA and Expressed as ELISA Units Which Are Derived by Dilution of Serum Samples Until the Result Falls on a Linear Portion of the Response Curve. Final Values Are Derived From ELISA Units and the Serum Dilution

Side effects data

From 2009 Phase 4 trial • 60 Patients • NCT00624832
22%
Headache
17%
Nasopharyngitis
11%
Vertigo
6%
Wound complication
6%
Papilloma
6%
Infusion site erythema
6%
Eye pruritus
6%
Eye irritation
6%
Toothache
6%
Injection site swelling
6%
Conjunctivitis
6%
Herpes virus infection
6%
Dyspnoea
6%
Hypertension
6%
Viral infection
6%
Cough
100%
80%
60%
40%
20%
0%
Study treatment Arm
Xolair (IgE= 30- 300 IU/mL)
Xolair (IgE= 700- 2000 IU/mL)
Xolair (IgE= 301- 699 IU/mL)
Placebo Comparator

Trial Design

1Treatment groups
Experimental Treatment
Group I: xolairExperimental Treatment1 Intervention
This is a single arm, parallel study examining differences of therapeutic outcomes of Xolair. Xolair is being examined as an intervention that might change the outcome of immunization.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Omalizumab
FDA approved

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
373 Previous Clinical Trials
3,528,833 Total Patients Enrolled
2 Trials studying Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,232 Total Patients Enrolled
278 Trials studying Asthma
112,983 Patients Enrolled for Asthma
Mark Schuyler, MDStudy DirectorUNM HSC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Immune Dysfunction in Allergic Asthma
Mark Schuyler 2005. "Immune Dysfunction in Allergic Asthma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00189228.
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top